発酵食品におけるポリフェノルの代謝産物:生物変換,生物利用性,機能的役割

Nouf Abdullah Alharbi¹

¹Department of Basic Health Sciences, College of Applied Medical Sciences, Qassim University, Buraydah, Saudi Arabia.

Frontiers in nutrition

|February 16, 2026

まとめ

発酵は植物ポリフェノールを生物活性代謝産物に変えて,腸内吸収を高め,有益な腸内細菌を促進します. これらの変化は腸の健康を改善し,全身的な利点をもたらしますが,さらなる研究が必要です.

科学分野:

バイオケミストリーバイオケミストリー
微生物学微生物学とは
栄養科学栄養学栄養科学は,栄養学が,栄養学が,栄養学が,栄養学が,栄養学が,栄養学が,栄養学が,栄養学が,栄養学が,栄養学が,栄養学は,栄養学が,栄養学は,栄養学は,栄養学は,栄養学は,栄養学は,栄養学は,栄養学は,栄養学は,栄養学は,栄養学は

背景:

ポリフェノールは,抗酸化,抗炎症,抗微生物の性質を持つ植物化合物です.
発酵は微生物酵素を用いてポリフェノルを改変し,その生物利用性と生物活性性を高めます.

研究の目的:

発酵中のポリフェノールの変換を見直す.
その結果生じる生物活性代謝産物とその腸内微生物群と宿主の健康への影響について調べる.

主な方法:

発酵中のポリフェノール生物変換に焦点を当てた文献レビュー.
ポリフェノール構造,溶解性,安定性,および生物活性における変化の分析.
発酵ポリフェノール代謝物の腸内微生物群の構成と機能に対する影響の検討.

主要な成果:

発酵により,溶解性,安定性,抗酸化作用が強化された生物活性ポリフェノール代謝産物が生成されます.
これらの代謝産物は,消化管の吸収を改善し,腸内微生物群を調節し,ラクトバシルスやビフィドバクテリウムのような有益な細菌を促進します.
発酵されたポリフェノール代謝物は,腸の健康を改善し,炎症を軽減し,代謝,免疫,神経認知機能を向上させます.

結論:

発酵は,バイオトランスフォーメーションを通じてポリフェノールの健康上の利点を大幅に高めます.
微生物の経路を明らかにするためにさらなる研究が必要であり,全身的な健康結果を検証するためにヒトの研究を行う必要があります.

キーワード:

さらに関連する動画

14:53

Techniques for the Evolution of Robust Pentose-fermenting Yeast for Bioconversion of Lignocellulose to Ethanol

Published on: October 24, 2016

12.0K

06:54

Elucidating the Metabolism of 2,4-Dibromophenol in Plants

Published on: February 10, 2023

1.6K

関連する概念動画

01:16

Drug Biotransformation: Overview

3.9K

Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...

3.9K

01:28

Drug Biotransformation: Overview

3.4K

Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...

3.4K

01:19

Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

772

Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...

772

01:17

Oxidation of Phenols to Quinones

4.8K

In the presence of oxidizing agents, phenols are oxidized to quinones. Quinones can be easily reduced back to phenols using mild reducing agents. The electron-donating hydroxyl group enhances the reactivity of the aromatic ring, enabling oxidation of the ring even in the absence of an α hydrogen.
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...

4.8K

01:19

Phase I Oxidative Reactions: Overview

837

Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...

837

01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...

関連する実験動画